Download: PDF RTF XML Booklet: Review (0) Retrieve Add item
Innovative incentives for Effective Antibacterials [AMR-Conference] [20090001] - Conference
General objectives

The focus of the conference will be on the discrepancy between the antibiotic
resistance threat and the lack of new drugs foreseen in the pharmaceutical sector. The aim is to explore ways
of creating incentives for the development of new drugs. Such incentives could be changes in the regulatory
mechanisms, innovative financial instruments or other innovative mechanism.

Expected achievements

A special report is ordered from WHO regarding potential incentives for addressing the needs for the R&D
of antibiotics and possible successes or limitations of alternative models for innovation. The final version
will be published the 31 of October 2009. The report and outcome of the conference will also be the basis of
the Council Conclusions that the Swedish presidency is heading for.

Target audience

The meeting targets an audience of EU policy-makers, including a number of Health Ministers from Member
States, executive officers and experts from the public health sector and also industry trade associations.

Conference programme

Detailed Conference programme
Draft agenda for the workshop and conference “Innovative Incentives for Effective Antibacterials”, 16-17
September in Stockholm, Sweden.
16 September:Workshop 1-3
The workshops are scheduled to start 12.30 on September 16.
Workshop No 1 (W1) will look through possibilities of easing the way for antimicrobials through the
regulatory system. Tomas Salmonson will be chairman and Mair Powell rapporteur.
W2 will deal with financial and legislative measures to improve the throughout of new products. Richard
Laing of the WHO will be chairman and Chantal Morel, a collaborator of Elias Mossialos will be rapporteur.
W3 will review new targets and lines of research to get new antimicrobials.
17 September, Draft agenda for the conference
09.00-09.30 Introduction, including welcome address by Swedish Minister for Health and Social Affairs,
Mr Göran Hägglund
09.30-09.45 Description and overview of the problem from an expert perspective
09.45-10.15 The GAP-analysis, presentation by EMEA and/or ECDC
10.15-11.00 Presentation of Dr Mossialos report
11.00-11.30 Coffee break
11.30-12.30 Presentation of results from work-shops
12.30-14.00 Lunch
14.00-14.30 The Pharmaceutical industry’s perspective
14.30-16.15 Ministerial panel discussion incl. EU-KOM (DGs Research, SANCO and Enterprise), ECDC
and EMEA.
Concluding remarks
17.00. Closure of the Conference

Start date: 17/09/2009
End date: 17/05/2010
Duration: 8 month(s)
Current status: Finalised
Programme title: Second Programme of Community action in the Field of Health 2008-2013
EC Contribution: € 89 394,22